Novo Nordisk A/S News Headlines

NVO 
$46.8
*  
0.25
0.53%
Get NVO Alerts
*Delayed - data as of Mar. 5, 2015 15:02 ET  -  Find a broker to begin trading NVO now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    NVO Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Verdict on Glaxo's Lovaza - Analyst Blog
9/17/2013 9:58:45 AM - Zacks.com


Another Indication for Allergan's Botox - Analyst Blog
9/16/2013 3:58:40 PM - Zacks.com


Glaxo Reports Positive Data - Analyst Blog
9/16/2013 11:58:06 AM - Zacks.com


European Shares Rally After Summers Pulls Out of Running for Fed Chief, US and Russia Agree on Syria Deal
9/16/2013 11:14:12 AM - MT Newswires


Lixisenatide NDA Withdrawn by Sanofi - Analyst Blog
9/13/2013 9:58:15 AM - Zacks.com


Update on J&J/Genmab's Daratumumab - Analyst Blog
9/12/2013 11:57:53 AM - Zacks.com


AstraZeneca, Merck Ink Licensing Deal - Analyst Blog
9/12/2013 10:40:01 AM - Zacks.com


Another Prize Slips Through Novo's Hands As Big PBM Looks Elsewhere
9/4/2013 1:38:00 PM - Seeking Alpha


AstraZeneca Reports Onglyza Data - Analyst Blog
9/3/2013 4:30:01 PM - Zacks.com


Positive Data on Takeda's AlogliptIn - Analyst Blog
9/3/2013 3:35:01 PM - Zacks.com


Considering High-DGR Dividend Growth Stocks
9/3/2013 11:49:00 AM - Seeking Alpha


Jim Simons Buys Apple, Citigroup, McDonald's, Sells Google, PepsiCo, IBM
8/13/2013 8:54:44 AM - GuruFocus


Novo Nordisk Beats on Earnings & Sales - Analyst Blog
8/12/2013 12:35:46 PM - Zacks.com


Novo Nordisk Getting Its Trial By Fire
8/8/2013 4:00:00 PM - Investopedia


Approval Delayed for Glaxo Drug - Analyst Blog
8/6/2013 4:40:54 PM - Zacks.com


Rexahn's CEO Uses A Business-Driven Cancer Model For Shareholder Value
8/5/2013 6:34:00 PM - Seeking Alpha


Oramed Expands Diabetes Platform With Oral GLP-1 Agonist
8/5/2013 4:29:00 PM - Seeking Alpha


5 Upcoming Dividend Aristocrats You May Be Looking Past
7/23/2013 11:12:00 AM - Seeking Alpha


Merck's $5.7 Billion Diabetes Franchise Is Vulnerable
7/10/2013 9:44:00 AM - Seeking Alpha


Bayer Initiates Phase III Study - Analyst Blog
7/9/2013 5:05:01 PM - Zacks.com


Glaxo Initiates Phase III Study - Analyst Blog
7/8/2013 4:07:26 PM - Zacks.com


Bayer Announces Positive Phase I Data - Analyst Blog
7/8/2013 4:00:01 PM - Zacks.com


Label Expansion for Novartis' Lucentis - Analyst Blog
7/5/2013 4:05:01 PM - Zacks.com


Priority Review for Roche Candidate - Analyst Blog
7/5/2013 3:38:36 PM - Zacks.com


Novo In Need Of A Booster Shot
7/4/2013 5:58:00 AM - Seeking Alpha